Cat #: 11-725C

Zymo Research R3013-1K Quick SARS-CoV-2 Multiplex Kit (1000 rxns), Zymo Research, 1000 Rxns/Unit

Zymo Research R3013-1K Quick SARS-CoV-2 Multiplex Kit (1000 rxns), Zymo Research, 1000 Rxns/Unit primary image
Zymo Research R3013-1K Quick SARS-CoV-2 Multiplex Kit (1000 rxns), Zymo Research, 1000 Rxns/Unit primary image
Zymo Research R3013-1K Quick SARS-CoV-2 Multiplex Kit (1000 rxns), Zymo Research, 1000 Rxns/Unit primary image

Cat #: 11-725C

Zymo Research R3013-1K Quick SARS-CoV-2 Multiplex Kit (1000 rxns), Zymo Research, 1000 Rxns/Unit


Zymo Research

1000 Rxns/Unit

Brand: Zymo Research

  • High Sensitivity: Limit of Detection as low as 10 GEC/reaction (167 GEC/ml)
  • Rapid & Easy Setup: Ready-to-use Master Mix, just add sample
  • Compatible with Automated and High-Throughput workflows

Guest Price:
$4,962.80
List Price: $8,250.25
Have a Genesee Account?
Login To Access Your Institutional Price

Zymo Research

1000 Rxns/Unit

Brand: Zymo Research

  • High Sensitivity: Limit of Detection as low as 10 GEC/reaction (167 GEC/ml)
  • Rapid & Easy Setup: Ready-to-use Master Mix, just add sample
  • Compatible with Automated and High-Throughput workflows

The Quick SARS-CoV-2 Multiplex Kit is a real-time reverse transcription PCR (rRT-PCR) test for the qualitative detection of RNA from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which is responsible for the coronavirus disease (COVID-19).

Brand Zymo Research Corporation
Compatibility Compatible with automated and high-throughput workflows.
Equipment Required Real-Time PCR Instruments capable of detecting HEX/VIC and Quasar® 670/Cy5 fluorophores. Adjustments of the RT-PCR parameters may be necessary for instruments different than the CFX96 Touch from Bio-Rad.
Input Quality Purified RNA free of enzymatic inhibitors.
Processing Time </= 2 hours from set up to results.
Reagents Complete and ready to use master mix.
Registration Status CE-IVD Marked
Sample Input Material Purified RNA from upper respiratory and lower respiratory systems.

This test has not been FDA cleared or approved. In the USA this test can be adopted in clinical diagnostics laboratories as an LDT according to local state guidelines. The test can be used for RUO/Informational purposes. The test is currently pending for CE IVD certification.

This test detects specifically SARS-CoV-2 and cannot be used to detect other viruses or pathogens.

Please refer to the Interpretation of Results, the Appendix, and the Troubleshooting Guide sections in our Quick SARS-CoV-2 Multiplex Kit protocol.

Sometimes aberrant qPCR signal are observed. Please refer to the Interpretation of Results, the Appendix, and the Troubleshooting Guide sections in our Quick SARS-CoV-2 Multiplex Kit protocol.

This may indicate incorrect plate set-up or a contamination in the No-Template Control or in the 2X CV Mix. We recommend repeating the test, and if the problem persists to use a new aliquot of reagents.

If using RT-PCR instruments different than the CFX96 Touch from Bio-Rad, this problem can be solved by adjusting the RT-PCR parameters (e.g. baseline threshold, temperature ramp, ...). This problem may also indicate incorrect plate set up of the compromise of Quick SARS-CoV-2 reagents.

With a limit of detection(LoD) as low as 10 GEC/reaction the Quick SARS-CoV-2 Multiplex Kit outperforms most of the SARS-CoV-2 molecular tests present on the market. In addition, the detection of a host target (human Rnase P) allow the identification of insufficient samples, which other tests may classify as negative; this further reduce the chances of the false negative results.

Enjoy our products? Leave a review and let us know.